Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
Status:
Recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
The CSP-001-FOL1 clinical study is aimed to investigate whether local topical administration
of FOL100 lotion will be safe for the patient and will not cause local or systemic skin or
other adverse events. It is also aimed at indicating effectiveness as compared with oral
Finasteride 1mg. In this non-blinded study, each patient will choose his preferred arm (oral
finasteride or FOL100 location). During the study, safety and efficacy will be measured as
well as usability.